Комплексы полупроводниковых нанокристаллов и рекомбнантных антител для флуоресцентной визуализации опухолевых клеток
Диссертация
Указанные рецепторы являются мишенями противоопухолевых антител, разрешенных к терапевтическому применению, и их выявление в опухолевой ткани является важным диагностическим и прогностическим признаком, позволяющим скорректировать лечение и правильно подобрать терапевтические агенты. Кроме того, высокая изменчивость 5 раковых клеток, часто приводящая к неэффективности лечения анти-НЕШ… Читать ещё >
Список литературы
- Adams G.P., Schier R., McCall A.M., Simmons H.H., Horak E.M., Alpaugh R.K., Marks J.D., Weiner L.M. High affinity restricts the localization and tumor penetration of single-chain fV antibody molecules // Cancer Res. 2001. V. 61. P. 4750−4755.
- Akerman M.E., Chan W.C., Laakkonen P., Bhatia S.N., Ruoslahti E. Nanocrystal targeting in vivo // Proc. Natl. Acad. Sci. USA. 2002. V. 99. P. 12 617−12 621.
- Aldana J., Wang Y.A., Peng X. Photochemical instability of CdSenanocrystals coated by hydrophilic thiols // J. Am. Chem. Soc. 2001. V. 123. P. 8844−8850.
- Alivisatos P. The use of nanocrystals in biological detection // Nature Biotechnol. 2004. V. 22. P. 47−52.
- Ballou B., Lagerholm B.C., Ernst L.A., Bruchez M.P., Waggoner A.S. Noninvasive imaging of quantum dots in mice// Bioconjug. Chem. 2004. V. 15. P: 79−86.
- Batra S.K., Jain M., Wittel U.A., Chauhan S.C., Colcher D. Pharmacokinetics- and biodistribution of genetically engineered antibodies// Curr. Opin. Biotechnol. 2002. V. 13. P. 603−608.
- Bennett M.J., Schlunegger M.P., Eisenberg D. 3D domain swapping: a mechanism for oligomers assembly // Prot. Sci. 1995. V. 4. P. 2455−2468>
- Bharali D.J., Lucey D.W., Jayakumar H., Pudavar H.E., Prasad P.N. Folate-receptor-mediated delivery of InP quantum dots for bioimaging using confocal and two-photon microscopy // J. Am. Chem. Soc 2005. V. 127. P. 11 364−11 371.
- Bird R.E., Hardman K.D., Jacobson J.W., Johnson S., Kaufman B. M., Lee S., M., Lee T., Pope S. H., Riordan G. Si, Whitlow M. Single-chain antigen-binding proteins // Science. 1988. V. 242. P. 423—426.
- Bouzigues C., Levi S., Triller A., Dahan M. Single quantum dot tracking of membrane receptors // Methods Mol. Biol. 2007. V. 374. P. 81−91.
- Bruchez M.Jr., Moronne M., Gin P., Weiss S., Alivisatos A.P. Semiconductor nanocrystals as fluorescent biological labels // Science. 1998. V. 281. P. 2013−2016.
- Bullen C., Mulvaney P. The effects of chemisorption on the luminescence of CdSe quantum dots // Langmuir. 2006. Y.22. P. 3007−3013.
- Cai W., Shin D.W., Chen K., Gheysens O., Cao Q., Wang S.X., Gambhir S.S., Chen X. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects // Nano Lett. 2006. V. 6. P. 669−676.
- Carter P., Presta L., Gorman C.M., Ridgway J.B., Henner D., Wong W.L., Rowland A.M., Kotls C., Carter M.E., Shepard H.M. Humanization of an anti-pl85HER2 antibody for human cancer therapy // Proc. Natl. Acad: Sci. USA. 1992. V. 89.- P. 4285−4289.
- Chan W.C., Maxwell D.J., Gao X., Bailey R.E., Han M., Nie S. Luminescent quantum dots for multiplexed biological detection and imaging // Curr. Opin. Biotechnol. 2002. V. 13. P. 40−46.
- Chan W.C., Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection // Science. 1998. V. 281. P. 2016−2018.
- Chen C., Peng J., Xia H., Yang G., Wu Q., Chen L., Zeng L., Zhang Z., Pang D., Li Y. Quantum* dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer // Biomaterials. 2009. V. 30. P.'2912−2918:
- Chen L.D., Liu J., Yu X.F., He M., Pei X.F., Tang Z.Y., Wang Q.Q., Pang DiW., Li Y. The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis // Biomaterials. 2008. V. 29.- P. 4170−4176.
- Cho S.J., Maysinger D., Jain M., Roder B., Hackbarth S., Winnik F.M. Long-term exposure to CdTe quantum dots causes functional impairments in live cells // Langmuir. 2007. V. 23. P. 1974−1980.
- Choi H.S., Liu W., Liu F., Nasr K., Misra P., Bawendi M.G., Frangioni J.V. Design considerations for tumour-targeted nanoparticles // Nat. Nanotechnol. 2010. V. 5. P. 42−47.
- Choi H.S., Liu W., Misra P., Tanaka, E., Zimmer J.P., Itty Ipe B., Bawendi M.G., Frangioni J.V. Renal clearance of quantum dots //Nat. Biotechnol. 2007. V. 25. P. 1165−1170.
- Chu T.C., Shieh F., Lavery L.A., Levy M., Kortum R.R., Korgel B. A, Ellington A.D. Labeling tumor cells with fluorescent nanocrystal-aptamerbioconjugates // Biosens. Bioelectron. 2006. V.21.P. 1859−1866.
- Chudakov D.M., Lukyanov S., Lukyanov K.A. Fluorescent proteins as a toolkit for in vivo imaging // Trends Biotechnol. 2005. V. 23. P. 605−613.
- Corlu A., Choe R., Durduran T., Rosen M.A., Schweiger M., Arridge S.R., Schnall M.D., Yodh A.G. Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans // Optics Express. 2007. V. 15. P. 6696−6716.
- Dahan M. From analog to digital: exploring cell dynamics with single quantum dots // Histochem. Cell Biol. 2006.Y. 125. P. 451−456.
- Dahan M., Levi S., Luccardini C., Rostaing P., Riveau B., Triller A. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking // Science. 2003- V. 302. P. 442 445.
- Davis C.G., Gallo MIL., Corvalan J.R. Transgenic mice as a source of fully human antibodies for the treatment of cancer //Cancer Metastasis Rev. 1999. V. 18: P.421−425.
- Deyev S.M., Lebedenko E.N. Multivalency: the hallmark of antibodies used' for optimization of tumor targeting by design // Bioessays. 2008. V. 30. P. 904−918:
- Deyev S.M., Waibel R., Lebedenko E.N., Schubiger A.P., Pluckthun A.- Design of multivalent complexes using the barnase-barstar module // Nat. Biotechnol. 2003. V. 21. P. 1486−1492.
- Diagaradjane P., Orenstein-Cardona J.M., Colon-Casasnovas N.E., Deorukhkar A., Shentu S., Kuno N. Schwartz D: L., Gelovani J.G., Krishnan S. // Clin. Cancer Res. 2008. V. 14. P. 731−741.
- Dobrovolskaia M.A., McNeil S.E. Immunological properties of engineered nanomaterials //Nat. Nanotechnol. 2007. V. 2. P. 469−478.
- Duan H., Nie S. Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings // J. Am. Chem. Soc. 2007. V. 129. P. 3333−3338.
- Edelweiss E., Balandin T.G., Ivanova J.L., Lutsenko G.V., Leonova O.G., Popenko V.I., Sapozhnikov A.M., Deyev S.M. Barnase as a new therapeutic agent triggering apoptosis in human cancer cells // PLoS ONE. 2008. V. 3. P. e2434.
- Eigenbrot C., RandalM., PrestaL., CarterP., KossiakoffA.A. X-ray structures of the antigen-binding domains from three variants of humanized anti-p 185HER2 antibody 4D5 and comparison with molecular modeling // J. Mol. Biol. 1993. V. 229. P. 969−995.
- Estrada C.R., Salanga M., Bielenberg D.R., Harrell W.B., Zurakowski D., Zhu X., Palmer M.R., Freeman M.R., Adam R.M. Behavioral profiling of human transitional cell carcinoma ex vivo // Cancer Res. 2006. V. 66. P. 3078−3086.
- Fischer H., Liu L., Pang K.S., Chan W. Pharmacokinetics of nanoscale quantum dots: in vivo distribution, sequestration, and clearance in the rat // Adv. Funct. Mater. 2006. V. 16. P. 1299−1305.
- GreenN.M: Avidin and streptavidin // Methods Enzymol. 1990: V. 184. P. 51−67.
- Hainfeld J.F., Liu W., Halsey C.M.R., Freimuth P., Powell R.D. Ni-NTAgold clusters target His-tagged proteins // J. Stuct. Biol- 1999: V. 127. P.' 185−198-:
- Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors // Environ. Health Perspect. 2006. V. 114. P. 165−172.
- Hartley R.W., Rogerson D.L. Production and purification of the extracellular ribonuclease of Bacillus amyloliquefaciens (barnase) and its intracellular inhibitor (barstar). I. Barnase // Prep.Biochem. 1972. V. 2. P. 229−242.
- Hauck T.S., Anderson R.E., Fischer H.C., Newbigging S., Chan W.C. In vivo quantum-dot toxicity assessment// Small. 2010. V. 6. P. 138−144.
- Hermanson G.T. Bioconjugate techniques // Academic Press. 1996. 785 pp.
- Hoshino A., Fujioka K., Oku T., Suga M., Sasaki Y., Ohta T.S., Yasuhara M., Suzuki K., Yamamoto K. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification // Nano Lett. 2004. V. 4. P: 2163−2169.
- Hoshino A., Hanada S., Manabe N., Nakayama T., Yamamoto K. Immune response induced by fluorescent nanocrystal quantum dots in vitro and in vivo // IEEE Trans. Nanobioscience. 2009. V. 8. P. 51−57.
- Hynes N.E., Gerber H.A., Saurer S., Roner B. Overexpression of the c-erbB-2 protein in human breast tumor cell lines // J. Cell. Biochem. 1989. V. 39. P. 167−173.
- Jain R.K. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function // J. Control. Release. 2001. V. 74. P. 7−25.
- Jaiswal J.K., Mattoussi H., Mauro J.M., Simon S.M. Long-term multiple color-imaging of live cells using quantum dot bioconjugates // Nat. Biotechnol. 2003. V. 21. P.* 47−51.
- Kairdolf B.A., Mancini M.C., Smith A.M., Nie S. Minimizing nonspecific cellular binding of quantum dots with hydroxyl-derivatized surface coatings // Anal. Chem. 2008. V. 80. P. 3029−3034.
- Kawashima N., Nakayama K., Itoh K., Itoh T., Ishikawa M., Biju V. Reversible dimerization of EGFR revealed by single-molecule fluorescence imaging using quantum dots // Chemistry. 2010. V. 16. P. 1186−1192.
- Keif T.A., Sreenivasan V.K., Sun J., Kim E.J., Goldys E.M., Zvyagin A.V. Non-specific cellular uptake of surface-functionalized quantum dots //Nanotechnology. 2010. V. 21. e285105.
- King D.J., Turner A., Farnsworth A.P., Adair J.R., Owens- R.J., et al. Improved tumor targeting with chemically cross-linked recombinant antibody fragments // Cancer Res. 1994. V. 54. P. 6176−6185.
- Kipriyanov S.M., Moldenhauer G., Schuhmacher J., Cochlovius B., Yon der Lieth C.W., et al. Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics //J. Mol. Biol. 1999. V. 293. P. 41−56-
- Kirchner C., Liedl T., Kudera S., Pellegrino T., Javier A.M., Gaub H.E., Stolzle S., Fertig N., Parak W.J. Cytotoxicity of colloidal1 CdSe and CdSe/ZnS nanoparticles // Nano Lett. 2005. V.5.P. 331−338.
- Laemmli U.K., Beguin F., Gujer-Kellenberger, G. A factor preventing the major head, protein of bacteriophage T4 from random aggregation // J. Mol. Biol. .1970. V." 47. P: 69−85.
- Larson D.R., Zipfel W.R., Williams R. M1, Clark S.W., Bruchez M.P., Wise F.W., Webb W.W. Water-soluble quantum-dots for multiphoton fluorescence imaging in vivo // Science. 2003. V. 300. P: 1434−1436.
- Lebedenko E.N., Balandin T.G., Edelweiss E.F., Georgiev O., Moiseeva E.S., Deyev S.M. Visualization of cancer cells by means of the fluorescent EGFP-barnase protein // Dokl. Biochem. Biophys. 2007. V. 414. P. 120−123.
- Li Z., Wang K., Tan W., Li J., Fu Z., Ma C., Li H., He X, Liu J. Immunofluorescent labeling of cancer cells with quantum dots synthesized in aqueous solution // Anal. Biochem. 2006. V. 354. P. 169−174.
- Lidke D.S., Nagy P., Heintzmann R., Arndt-Jovin D.J., Post J.N., Grecco H.E., Jares-Erijman E.A., Jovin T.M. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction //Nat. Biotechnol. 2004. V. 22. P. 198−203.
- Lidke D.S., Nagy P., Jovin T.M., Arndt-Jovin D.J. Biotin-ligand complexes with streptavidin quantum dots for in vivo cell labeling of membrane receptors // Methods Mol. Biol. 2004. P. 69−79.
- Lin X., Xie J., Chen X. Protein-based'tumor molecular imaging probes // Amino Acids. 2010. DOI: 10.1007/s00726−010−0545-z
- Lovric J., Cho S.J., Winnik F.M., Maysinger D. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death// Chem. Biol. 2005. V. 12. P. 1227−1234.
- Luciani A., Itti E., Rahmouni A., Meignan M., Clement O. Lymph’node imaging: basic principles.//Eur. J. Radiol. 2006. V.58. P. 338−344.
- Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review // J. Control. Release. 2000. V. 65. P. 271 284.
- Mahmoud W., Sukhanova A., Oleinikov V., Rakovich Y.P., Donegan J.F., Pluot M., Cohen J.H., Volkov Y., Nabiev I. Emerging applications of fluorescent nanocrystals quantum dots for micrometastases detection // Proteomics. 2010. V. 10. P. 700−716.
- Makrides S.C., Gasbarro C., Bello J.M. Bioconjugation of quantum dot luminescent probes for Western blot analysis // Biotechniques. 2005. V. 39. 501−506.
- Mancini M.C., Kairdolf B.A., Smith AM., Nie S. Oxidative quenching and degradation of polymer-encapsulated quantum* dots: new insights into the long-term fate and, toxicity of nanocrystals in vivo II J. Am. Chem. Soc. 2008. V. 130. P: 10 836−10 837.
- Mattoussi H., Mauro J.M., Goldman E.R., Anderson G.P., Sundar V.C., Mikulec F.V., BawendiM.G.Self-assemly of CdSe-ZnS quantum dots bioconjugates using an engineered recombinant protein//J. Am. Chem. Soc. 2000.V.122. P. 12 142−12 150.
- Medintz I.L., Uyeda H.T., Goldman E.R., Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing //Nat. Mater. 2005 V. 4. P. 435−446.
- Melkko S., Halin C., Borsi L. Zardi L, Neri D. An antibody-calmodulin fusion protein reveals a functional dependence between macromolecular isoelectric point and tumor targeting performance // Int. J. Radiat. Oncol. Biol. Phys. 2002. V. 46. P. 726−733.
- Miiller K.M., Arndt K.M., Strittmatter W., Pluckthun A. The first constant domain (C (H)1 and C (L)) of an antibody used as heterodimerization domain for bispecificminiantibodies // FEBS Lett. 1998. Y. 422. P. 259−264.
- Parak W. J-, Gerion D-, Pellegrino T., Zanchet D-, Micheel C., Williams S.C., Alivisatos A.P., Boudreau R., Le Gros M.A., Larabell C.A. Biological- applications of colloidal nanocrystals//Nanotech: 2003. V. 14- P. 15−27.
- Pathak S., Davidson M.C., Silva G.A. Characterization of the functional binding properties of antibody conjugated quantum dots //Nano Lett. 2007. V. 7. P. 1839−1845.
- Pellegrino T., Manna L., Kudera S. Hydrophobic nanocrystals coated with an amphiphilic polymer shell: a general route to water soluble nanocrystals // Nano Lett. 2004. V. 4. P. 703−707.
- Pelley J.L., Daar A.S., Saner M.A. State of academic knowledge on toxicity and biological fate of quantum dots // Toxicol. Sci. 2009. V. 112. P. 276−296.
- Pinaud F., King D, Moore H.-P., Weiss S. Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. // J. Am. Chem. Soc. 2004. V. 126. P. 6115−6123.
- Prior T.I., Helman L.J., Fitz Gerald D.J., Pastan I. Barnase toxin: a new chimeric toxin composed of pseudomonas exotoxin A and barnase // Cancer Res. 1991.V. 51. P. 174−180.
- Ramachandran S., Udgaonkar J.B. Stabilization of barstar by chemical modification-of the buried cysteines // Biochemistry. 1996: V. 35. P. 8776−8785.
- Ravizzini G., Turkbey B., Barrett T., Kobayashi II., Choyke P.L. Nanoparticles in sentinel lymph node mapping // Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009. V. 1. P. 610−23.
- Resh-Genger U., Grabollel M., Cavaliere-Jaricot S., Nitschke R., Nann T. Quantum dots versus organic dyes as fluorescent labels nature methods // Nat. methods. 2008. V. 5. P. 763−775.
- Riechmann L, Clark M, Waldmann H, Winter G. Reshaping human antibodies for therapy//Nature. 1988: V. 332. P! 323−327.
- Rodrigues M.L., Snedecor B, Chen C., Wong W.L., Garg S. et al. Engineering Fab fragments for efficient F (ab)2 formation in Escherichia coli and for improved in vivo stability // J.Immunol. 1993. V. 151. P. 6954−6961.
- Rogach A.L., Katsikas L., Kornowski A., Su D., Eychmiiller A., Weller H. Synthesis and Characterization of Thiol-Stabilized CdTeNanocrystals // Ber. Bunsenges Phys. Chem. 1996. V. 100. P. 1772−1778.
- Ross J.S., Gray K., Gray G.S., Worland P.J., Rolfe M. Anticancer antibodies // Am. J. Clin. Pathol. 2003. V. 119. P. 472−485.
- Rushizky G.W., Greco A.E., Hartley R.W., Sober H.A. Studies on B. subtilisribonuclease I. Characterization of enzymatic specifity // Biochemistry. 1963. Y.2. P. 787−793.
- Rzigalinski B.A., Strobl J.S. Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots // Toxicol. Appl. Pharmacol. 2009. V. 238. P. 280−288.
- Saga T., Weinstein J.N., Jeong J.M., Heya T., Lee J.T. et al. Two-step targeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin // Cancer Res. 1994. V. 54. P. 2160−2165.
- Semenyuk E.G., Stremovskiy O.A., Edelweiss E.F., Shirshikova O.V., Balandin T.G., et al. Expression of single-chain antibody-barstar fusion in plants // Biochimie. 2007. V. 89. P.31— 38.
- Serebrovskaya E.O., Edelweiss E.F., Stremovskiy O.A., Lukyanov K.A., Chudakov D.M., Deyev S.M. Targeting cancer cells by using an antireceptor antibody-photosensitizer fusion protein //Natl. Acad. Sci. U S A. 2009. V. 106. P. 9221−9225.
- Sergina N.V., Moasser M.M. The HER family and cancer: emerging molecular mechanisms and therapeutic targets // Trends Mol. Med. 2007. V. 13. P. 527−534.
- Shi C., Zhu Y., Xie Z., Qian W., Hsieh C.L., Nie S., Su Y., Zhau H. E,. Chung L.W. Visualizing human prostate cancer cells in mouse skeleton using bioconjugated near-infrared fluorescent quantum dots // Urology. 2009. V. 74. P. 446−451.
- Simmons D.P., Abregu F.A., Krishnan U.V., Proll D.F., Streltsov V.A. Dimerisation strategies for shark IgNAR single domain antibody fragments // J. Immunol. Methods. 2006. V. 315. P: 171−184.
- Slocik J. M., Moore J. T. s Wright D.W. Monoclonal antibody recognition of histidine-rich peptide encapsulated nanoclusters //Nano Lett. 2002. V. 2. P. 169−173.
- Smith A.M., Dave S., Nie S. True L., Gao X. A systematic examination of surface coatings on the optical and chemical properties of semiconductor quantum dots // Expert Rev. Mol. Diagn. 2006. V. 6. P. 231−244.
- Su Y., He Y., Lu H., Sai L., Li Q., Li W., Wang L., Shen P., Huang Q., Fan C. The cytotoxicity of cadmium based, aqueous phase-synthesized, quantum dots and its modulation by surface coating // Biomaterials. 2009. V. 30. P. 19−25.
- Sukhanova A., Devy J., Venteo L., Kaplan H., Artemyev M., Oleinikov V., Klinov D., Pluot M., Cohen J.H., Nabiev I. Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells // Anal. Biochem. 2004. Y. 324. P. 60−67.
- Tada H., Higuchi T.M., Wanatabe N., Ohuchi N. In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice // Cancer Res. 2007. V. 67. P. 1138−1144.
- Wang C., Gao X., Su X. In vitro and in vivo imaging with quantum dots // Anal. Bioanal. Chem. 2010. V. 397. P. 1397−415.
- Weissleder R. A clearer vision for in vivo imaging // Nat.Biotechnol.2001. V. 19. P. 316 317.
- Weissleder R., Pittet M.J. Imaging in the era of molecular oncology // Nature.2008. V. 452. P. 580−589.
- Willmann J.K., van Bruggen N., Dinkelborg L.M., Gambhir S.S. Molecular imaging in drug development //Nat. Rev. Drug.Discov.2008. V. 7. P. 591−607.
- Wu A.M., Senter P: D. Arming antibody: prospects and challenges for immunoconjugates // Nat. Biotechnol. 2005. V. 23. P. 1137−1146.
- Wu A.M., Yazaki. P.J. Designer genes: recombinant antibody fragments for biological imaging // Q. J. Nucl. Med. 2000. V. 44. P. 268−283.
- Wu M.X., Liu H., Haley K.N., Treadway J.A., Larson J.P. Ge N., Peale F" Bruchez M. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots //Nat. Biotechnol. 2003. V. 21. P. 4116.
- Xue F. L., ChenJ. Y., GuoJ., WangC. C., YangW. L., WangP. N., LuD. R. Enhancement of intracellular delivery of CdTe quantum dots QDs to living cells by Tat conjugation // J. Fluoresc. 2007. 17. P. 149−154.
- Yang R.H., Chang L.W., Wu J.P. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment // Environ. Health. Perspect. 2007. V. 115. P. 1339−1343.
- Yong K.-T., Ding H., Roy I., Law W.-C., Bergey E.J., Maitra A., Prasad P.N. Imaging pancreatic cancer using bioconjugatedlnP quantum dots // ACS Nano. 2009. V. 3. P. 502−510.
- Zhang H., Cui Z., Wang Y., Zhang K., Ji X., Lu C., Yang В., Gao M.Y. From water-soluble CdTenanocrystals to fluorescent nanocrystal-polymer transparent composites using polymerizable surfactants // Adv. Mater. 2003. V. 15. P. 777−780.
- Zhang H., Sachdev D., Wang C., Hubel A., Gaillard-Kelly M., Yee D: Detection and downregulation of type I IGF receptor expression by antibody-conjugated quantum dots in breast cancer cells // Breast Cancer Res Treat. 2009. V. 114. P. 277−285.
- Zhang J., Jia X., Lv X.J., Deng Y.L., Xie HY. Fluorescent quantum- dot-labeled aptamerbioprobes specifically targeting mouse liver cancer cells // Talanta. 2010. V. 81. P. 505 509
- Zhou M., Ghosh I. Current trends in peptide science quantum dots and peptides: a bright future together // Biopolymers. 2007. V. 88. P. 325−339.
- Беляева^ Т.Н., Салова A.B., Леонтьева E.A., Моженок Т. П., Корнилова Е. С., Кроленко С. А. Нецелевые квантовые точки в прижизненных конфокально-микроскопических исследованиях клеток // Цитология. 2009.' Т. 51. С. 830−836.
- Деев С.М., Лебеденко Е. Н. Инженерия антител: молекулярный конструктор на1 основе барназа-барстар // Биоорган, химия. 2009. Т. 35. С. 761−778.
- Деев С.М., ЛебеденкоЕ.Н. Современные технологии создания неприродных антител для клинического применения // Acta Naturae. 2009. Т. 1. С. 32−50.
- Лебеденко- Е.Н., Баландин- Т.Г., Эдельвейс Э. Ф., Георгиев О., Моисеева Е. С., Петров Р. В., Деев С. М. // Докл. РАН. 2007. Т. 414. С. 408−411.
- ОлейниковВ.А., СухановаА.В., НабиевИ.Р. Флуоресцентные полупроводниковые нанокристаллы в биологии и медицине // Российские нанотехнологии. 2007. Т. 2. С. 160 173.
- Патрушев Л.И. Искусственные генетические системы Т.1: Генная и белковая инженерия // М.: Наука. 2004. 526 стр. /